m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00511
|
[1], [2], [3], [4], [5] | |||
: modification sites
Indirect
Enhancement
m6A modification
PTEN
PTEN
METTL3
Methylation
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | Mutated in multiple advanced cancers 1 (PTEN) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> Adenosine-to-Inosine editing (A-to-I) | ||||
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | WRITER | View Details | ||
| Regulated Target | hsa-mir-18a | View Details | |||
| Crosstalk Relationship | A-to-I → m6A | Enhancement | |||
| Crosstalk Mechanism | RNA modification indirectly impacts m6A modification through downstream signaling pathways | ||||
| Crosstalk Summary | ADAR1 interacts with hsa-mir-18a, increasing it's A-to-I level and promoting its physical interaction with Mutated in multiple advanced cancers 1 (PTEN), which was regulated by METTL3-mediated m6A modification. | ||||
In-vitro Model |
MOLM-13 | Adult acute myeloid leukemia | Homo sapiens | CVCL_2119 | |
| ARPE-19 | Normal | Homo sapiens | CVCL_0145 | ||
| K-562 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0004 | ||
| CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | ||
| HN4 | Clear cell renal cell carcinoma | Homo sapiens | CVCL_IS30 | ||
References
: modification sites
: m6A sites